China unveils world’s first blockchain-based IVF service application
MyBaby is the first service of its kind to combine the merits of third-party data verification with the immutability of blockchain technology
In partnership with VeChain and DNV, Renji Hospital, a leading hospital in China Shanghai Jiaotong University Medical School affiliated announced the launch of a smart medical care project – MyBaby, the world’s first blockchain-based in vitro fertilization (IVF) service application.
The MyBaby launch ceremony was jointly hosted by the Reproductive Medicine Center of Renji Hospital and the Shanghai Quality Control Center for Assisted Human Reproduction Technology.
By combining DNV’s professional insurance services with VeChain’s advanced blockchain technology, MyBaby enables verification of key in vitro fertilization (IVF) stages and provides private, exclusive, end-to-end access to data for future parents being treated. By adopting advanced technology, Renji Hospital is committed to further improving the equity and quality of life for patients.
MyBaby is the first service of its kind to combine the merits of third-party data verification with the immutability of blockchain technology. All information, images and data tracks, from images produced by medical tools to delivery of the zygote itself, will be uploaded securely to the VeChainThor blockchain and accessible only to authorized users of the MyBaby app.
MyBaby allows users to view and track the extraction, labeling and scoring of fertilized eggs as well as the cultivation and storage of embryos. The app also solves traditional issues related to the privacy of sensitive medical data. The cryptographically secure properties of blockchain technology create a secure and reliable environment and improve the user experience in a way unprecedented in the field of IVF.